| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84bd1e0f7cf835178d33357af82fffda
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72d94b9abca7ae09fd0101e3d877a21e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ce91d3ddb5a95219a0b433843e66ed5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4fda45c540f11df3a7fe71d54a70562a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5585 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5585 |
| filingDate |
2007-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42b4435dc4e049f7c891184132e54771 |
| publicationDate |
2020-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-PI0707488-B1 |
| titleOfInvention |
METHOD FOR THE PRODUCTION OF AN EPOPROSTENOL COMPOSITION, PHARMACEUTICAL COMPOSITION AND STABLE SOLUTION |
| abstract |
method for producing an epoprostenol composition, pharmaceutical composition and stable solution. the invention relates to a stable epoprostenol composition that can be combined with commercially available iv fluids and can be administered in reconstituted and / or diluted form under environmental conditions of about 15-30 <198> and for more than 24 hours. the composition preferably contains (a) epoprostenol or a salt thereof; (b) an alkalizing agent; and (c) a base, so that when reconstituted or in solution, the solution has a ph> 11. Methods for producing the lyophilized composition are also described. |
| priorityDate |
2006-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |